High-Yield Neurologic Discriminators: Rapid Two-Condition Comparisons
Many neurologic exam questions hinge on distinguishing two closely related conditions where a single discriminating feature drives diagnosis and management. This review pairs commonly confused entities and isolates the findings that separate them: CSF profiles, imaging characteristics, lesion patterns, antibody status, and clinical onset. Master the discriminator for each pair and you can convert a vignette into a diagnosis rapidly.
Bacterial vs Viral Meningitis
The CSF profile is the discriminator. Bacterial meningitis shows LOW glucose, HIGH protein, and a neutrophil (PMN) predominance, with a more toxic-appearing patient. Viral meningitis shows NORMAL glucose, only mildly elevated protein, and a lymphocytic predominance, with a comparatively less toxic presentation. When a vignette gives you low CSF glucose with PMNs, think bacterial; normal glucose with lymphocytes points to viral.
Ischemic vs Hemorrhagic Stroke
Both cause SUDDEN onset of focal neurologic deficits, so onset speed is NOT the discriminator. Instead, hemorrhagic stroke is favored by severe headache ('worst headache of my life'), vomiting, rapidly declining level of consciousness, and markedly elevated blood pressure, while pure ischemic stroke tends to lack these features. On imaging, hemorrhage is HYPERDENSE on non-contrast CT immediately, whereas ischemia may look normal acutely and only becomes HYPODENSE over hours to days. The management pivot is imaging-driven: you must obtain a non-contrast CT to exclude hemorrhage before giving IV thrombolysis (tPA/tenecteplase). Thrombolysis is the therapy that is absolutely contraindicated in hemorrhagic stroke. In acute ischemic stroke, treatment is IV thrombolysis (if within the time window) and/or mechanical thrombectomy, followed by antiplatelet therapy (aspirin); acute anticoagulation is generally NOT started because of hemorrhagic transformation risk and is reserved/delayed for secondary prevention in select cases such as atrial fibrillation.
Multiple Sclerosis vs Neuromyelitis Optica
Lesion pattern and antibody status are the discriminators. Multiple sclerosis produces multiple ovoid demyelinating plaques oriented perpendicular to the ventricles (Dawson fingers), and also involves juxtacortical, infratentorial, and spinal cord regions; cord lesions in MS are typically SHORT-segment (spanning fewer than three vertebral segments), and MS is aquaporin-4 antibody negative. Neuromyelitis optica produces longitudinally extensive transverse myelitis spanning three or more (\u22653) contiguous vertebral segments and is aquaporin-4 (AQP4-IgG) antibody positive. A long, contiguous cord lesion (\u22653 segments) with positive aquaporin-4 antibodies is NMO, not MS.
Guillain-Barre Syndrome vs Myasthenia Gravis
These differ in onset pattern, reflexes, course, and trigger. Guillain-Barre syndrome causes ascending weakness with areflexia, follows a monophasic course, and is typically post-infectious. Myasthenia gravis presents with ocular/bulbar onset, preserved (normal) reflexes, a chronic fluctuating course, and is autoimmune. Areflexia with ascending weakness after an infection is GBS; fluctuating ocular and bulbar weakness with normal reflexes is myasthenia gravis.
High-yield
- Low CSF glucose + high protein + PMNs = bacterial meningitis; normal glucose + lymphocytes = viral meningitis.
- CT hyperdensity is immediate in hemorrhagic stroke; hypodensity appears later in ischemic stroke.
- Both stroke types have sudden onset—hemorrhage is distinguished by severe headache, vomiting, and rapid decline in consciousness, not by a slower onset.
- IV thrombolysis (tPA) is the acute therapy absolutely contraindicated in hemorrhagic stroke; a non-contrast CT must exclude hemorrhage first.
- Acute ischemic stroke: thrombolysis and/or thrombectomy plus antiplatelet (aspirin); acute anticoagulation is generally avoided and reserved/delayed for secondary prevention (e.g., AFib).
- Aquaporin-4 antibodies: negative in MS, positive in neuromyelitis optica.
- MS cord lesions are short-segment (<3 vertebral segments) with ovoid periventricular plaques (Dawson fingers); LETM (\u22653 segments) favors NMO.
- GBS = ascending weakness, areflexia, monophasic, post-infectious.
- Myasthenia gravis = ocular/bulbar onset, normal reflexes, chronic fluctuating, autoimmune.
Pitfalls
- Confusing the CSF glucose direction—remember glucose is LOW (not normal) in bacterial meningitis.
- Thinking ischemic stroke has a 'gradual' onset—both ischemic and hemorrhagic strokes present with sudden focal deficits; the CT hypodensity of ischemia is what evolves over time, not the clinical onset.
- Naming anticoagulation as the acute stroke treatment at stake—the therapy that must be withheld until hemorrhage is excluded is IV thrombolysis (tPA); acute anticoagulation is generally not the acute intervention in either type.
- Assuming any transverse myelitis is MS—a long lesion (\u22653 segments) with aquaporin-4 antibodies is NMO, whereas MS cord lesions are short-segment (<3 segments).
- Describing MS lesions only as small periventricular dots—remember ovoid Dawson-finger plaques plus juxtacortical, infratentorial, and spinal cord involvement.
- Expecting hypodensity on immediate CT in ischemic stroke; the hypodense change evolves later, so an early normal CT does not exclude ischemia.
- Mislabeling myasthenia gravis as areflexic—reflexes are normal; areflexia belongs to GBS.
- Forgetting the onset clue: GBS begins ascending in the limbs, whereas myasthenia gravis starts with ocular/bulbar symptoms.
Clinical pearls
- A toxic-appearing patient with LOW CSF glucose and neutrophils demands treatment for bacterial meningitis.
- Sudden focal deficits with severe headache, vomiting, and depressed consciousness plus an immediately hyperdense CT = hemorrhagic stroke—withhold thrombolysis.
- Get a non-contrast CT to rule out hemorrhage before giving tPA in a candidate for thrombolysis.
- Positive aquaporin-4 antibody flips the diagnosis from MS to neuromyelitis optica.
- Post-infectious ascending weakness with lost reflexes is the classic Guillain-Barre script.
- Fluctuating weakness worst in ocular and bulbar muscles points to myasthenia gravis.
Frequently asked
How do I quickly tell bacterial from viral meningitis on CSF?
Bacterial meningitis has LOW glucose, HIGH protein, and PMN (neutrophil) predominance in a more toxic-appearing patient; viral meningitis has NORMAL glucose, only mildly elevated protein, and lymphocyte predominance.
Why does distinguishing ischemic from hemorrhagic stroke matter so much?
Because it determines whether you can give IV thrombolysis (tPA/tenecteplase). Thrombolysis is absolutely contraindicated in hemorrhagic stroke, so you must obtain a non-contrast CT to exclude hemorrhage before treating. Hemorrhage is hyperdense immediately on CT, whereas ischemia may look normal early and become hypodense later.
Is anticoagulation the treatment used in acute ischemic stroke?
No. Acute ischemic stroke is treated with IV thrombolysis (within the time window) and/or mechanical thrombectomy, followed by antiplatelet therapy such as aspirin. Immediate anticoagulation is generally avoided because of hemorrhagic transformation risk and is reserved or delayed for secondary prevention in select patients (e.g., atrial fibrillation).
Do ischemic and hemorrhagic strokes differ in speed of onset?
No—both classically produce sudden focal neurologic deficits. The clues that favor hemorrhage are severe headache, vomiting, rapidly declining level of consciousness, and markedly elevated blood pressure, not a slower onset.
What single lab best separates MS from neuromyelitis optica?
Aquaporin-4 (AQP4-IgG) antibodies: negative in multiple sclerosis, positive in neuromyelitis optica.
What lesion patterns distinguish MS from NMO?
MS shows ovoid periventricular plaques perpendicular to the ventricles (Dawson fingers) plus juxtacortical, infratentorial, and short-segment (<3 vertebral segments) cord lesions. NMO shows longitudinally extensive transverse myelitis spanning three or more (\u22653) contiguous vertebral segments.
How do reflexes help distinguish Guillain-Barre from myasthenia gravis?
Guillain-Barre causes areflexia, while myasthenia gravis has normal reflexes. Combine that with onset pattern—ascending weakness in GBS versus ocular/bulbar onset in myasthenia gravis.
What clinical course and trigger point toward GBS versus myasthenia gravis?
GBS is monophasic and typically post-infectious; myasthenia gravis is chronic and fluctuating and is autoimmune in origin.
Turn this into reasoning you can use on exam day — practice High-Yield Neurologic Discriminators on branching cases where your decisions shape the patient.